Lilly to acquire US radiopharmaceutical company POINT for $1.4bn

By NS Healthcare Staff Writer

04 Oct 23

POINT has two potential candidates in late-phase development, with several others in earlier stages of development, operates a…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Sanofi, Janssen partner on potential E. coli pathogenic vaccine

By NS Healthcare Staff Writer

04 Oct 23

According to the agreement, both firms will co-fund current and future research and development expenditures with Sanofi paying…

PharmaceuticalsPartnerships and Licensing Agreements

Capsida Biotherapeutics, Kate Therapeutics partner to produce KateTx’s next-gen gene therapies

By NS Healthcare Staff Writer

04 Oct 23

The collaboration aims to facilitate KateTx's initial internal portfolio of gene therapy programmes focused on muscle and heart…

PharmaceuticalsManufacturing

Baxter completes $4.5bn sale of BioPharma Solutions business

By NS Healthcare Staff Writer

03 Oct 23

Baxter’s BioPharma Solutions business will be renamed Simtra BioPharma Solutions (Simtra), which will continue to same solutions and…

PharmaceuticalsManufacturing

Clade Therapeutics buys cell therapy company Gadeta

By NS Healthcare Staff Writer

03 Oct 23

The acquisition equips Clade with preclinical cell therapy programmes, a g/d TCR discovery engine, and cell enhancement technologies…

PharmaceuticalsDrug discovery

Amicus Therapeutics and Blackstone Enter into $430 Million Strategic Financing Collaboration

By NS Healthcare Staff Writer

03 Oct 23

Refinancing of Current $400M Debt at Lower Cost and Improved Amortization Schedule

PharmaceuticalsPartnerships and Licensing Agreements

IAMA Therapeutics Announces Multi-Phase, Strategic Provider Agreement with Evotec

By NS Healthcare Staff Writer

03 Oct 23

The agreement expands the companies' existing relationship, which entails collaborating on IND-enabling preclinical studies for IAMA-6

PharmaceuticalsPartnerships and Licensing Agreements

Deka Biosciences Closes USD $20m Series B2 Financing Led by MPM BioImpact

By NS Healthcare Staff Writer

29 Sep 23

.The proceeds of the financing will support the advancement of Deka’s pipeline and drug product manufacturing as they…

PharmaceuticalsClinical trials

Ionis, Roche partner for two RNA-targeted programmes to treat AD and HD

By NS Healthcare Staff Writer

28 Sep 23

The Swiss pharmaceutical firm will obtain exclusive global rights to develop, manufacture, and market the medicines by making…

PharmaceuticalsPartnerships and Licensing Agreements

Ginkgo Bioworks, Pfizer announce multi-target RNA discovery collaboration

By NS Healthcare Staff Writer

28 Sep 23

Under the partnership, Pfizer will use Ginkgo's patented RNA technology to discover RNA-based drug candidates and in return,…

PharmaceuticalsDrug discovery